Finance

Lists
Why is OKYO up 3,60%?
Dive Deeper
OKYO:NASDAQ
OKYO Pharma Ltd
US$1,44
+3,60%
(+0,050) 1D
9 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OKYO...
Open
US$1,40
High
US$1,53
Low
US$1,35
Mkt. cap
74,52 ລ້ານ
Avg. vol.
74,36 ພັນ
Volume
115,55 ພັນ
52-wk high
US$3,20
52-wk low
US$1,26
EPS
US$-0,32
Beta
-0,03
Shares outstanding
52,48 ລ້ານ
No. of employees
5
Open
US$1,40
High
US$1,53
Low
US$1,35
Mkt. cap
74,52 ລ້ານ
Avg. vol.
74,36 ພັນ
Volume
115,55 ພັນ
52-wk high
US$3,20
52-wk low
US$1,26
EPS
US$-0,32
Beta
-0,03
Shares outstanding
52,48 ລ້ານ
No. of employees
5
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
1 ຊົ່ວໂມງກ່ອນ
A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
The Globe and Mail
The Globe and Mail
·
1 ຊົ່ວໂມງກ່ອນ
Streamex Receives Nasdaq Notice on Minimum Bid Price
Investor's Business Daily
Investor's Business Daily
·
7 ຊົ່ວໂມງກ່ອນ
Futures: 6 Stocks Near Buy Points; Big Earnings, Inflation Data Due
About OKYO Pharma Ltd
CEO-
Employees5
Founded2007
Headquarters-
SectorBiotechnology
Analyst ratings
Based on 2 analysts giving stock ratings to OKYO in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for OKYO in the last 3 months.
Highest
Current US$1,44
US$7,00 (+386,11%)
Average
US$6,00 (+316,67%)
Lowest
US$5,00 (+247,22%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
US$5,00
+247,2%
10/06/2026
Biren Amin
Piper Sandler
Buy
Maintained
US$7,00
+386,1%
08/27/2026
William Wood
B. Riley Securities
Buy
Initiated
US$5,00
+247,2%
12/08/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ມິ.ຖ. 2025
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
Revenue
-
-
-
-
Cost of goods sold
1,27 ລ້ານ
1,27 ລ້ານ
2,07 ລ້ານ
2,07 ລ້ານ
Cost of revenue
1,27 ລ້ານ
1,27 ລ້ານ
2,07 ລ້ານ
2,07 ລ້ານ
Research and development expenses
-22,02 ພັນ
-22,02 ພັນ
926,55 ພັນ
926,55 ພັນ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-22,02 ພັນ
-22,02 ພັນ
926,55 ພັນ
926,55 ພັນ
Total operating expenses
1,25 ລ້ານ
1,25 ລ້ານ
3,00 ລ້ານ
3,00 ລ້ານ
Operating income
-1,25 ລ້ານ
-1,25 ລ້ານ
-3,00 ລ້ານ
-3,00 ລ້ານ
Other non operating income
-
-
-140,00
-140,00
EBT including unusual items
-1,29 ລ້ານ
-1,29 ລ້ານ
-3,18 ລ້ານ
-3,18 ລ້ານ
EBT excluding unusual items
-1,29 ລ້ານ
-1,29 ລ້ານ
-3,18 ລ້ານ
-3,18 ລ້ານ
Income tax expense
26,00
26,00
3,97 ພັນ
3,97 ພັນ
Effective tax rate
-
-
-0,12%
-0,12%
Other operating expenses
-
-
-
-
Net income
-1,29 ລ້ານ
-1,29 ລ້ານ
-3,18 ລ້ານ
-3,18 ລ້ານ
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
16,05 ພັນ
16,05 ພັນ
Interest expense
-42,29 ພັນ
-42,29 ພັນ
-194,68 ພັນ
-194,68 ພັນ
Net interest expenses
-42,29 ພັນ
-42,29 ພັນ
-178,63 ພັນ
-178,63 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,25 ລ້ານ
-1,25 ລ້ານ
-3,00 ລ້ານ
-3,00 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google